nodes	percent_of_prediction	percent_of_DWPC	metapath
Tirofiban—Retroperitoneal haemorrhage—Pazopanib—kidney cancer	0.034	0.0823	CcSEcCtD
Tirofiban—Haemorrhage intracranial—Temsirolimus—kidney cancer	0.0161	0.0389	CcSEcCtD
Tirofiban—Haemoglobin decreased—Temsirolimus—kidney cancer	0.00958	0.0232	CcSEcCtD
Tirofiban—Haematemesis—Pazopanib—kidney cancer	0.00894	0.0216	CcSEcCtD
Tirofiban—Haemoptysis—Pazopanib—kidney cancer	0.00839	0.0203	CcSEcCtD
Tirofiban—Haemoglobin decreased—Everolimus—kidney cancer	0.00712	0.0172	CcSEcCtD
Tirofiban—Haematemesis—Everolimus—kidney cancer	0.00706	0.0171	CcSEcCtD
Tirofiban—Hypercholesterolaemia—Temsirolimus—kidney cancer	0.00697	0.0169	CcSEcCtD
Tirofiban—Haematemesis—Erlotinib—kidney cancer	0.00681	0.0165	CcSEcCtD
Tirofiban—Haemoptysis—Everolimus—kidney cancer	0.00662	0.016	CcSEcCtD
Tirofiban—Haemoglobin decreased—Sorafenib—kidney cancer	0.00618	0.015	CcSEcCtD
Tirofiban—Haemoglobin decreased—Sunitinib—kidney cancer	0.00595	0.0144	CcSEcCtD
Tirofiban—Haematemesis—Sunitinib—kidney cancer	0.00589	0.0143	CcSEcCtD
Tirofiban—Haemoptysis—Sunitinib—kidney cancer	0.00553	0.0134	CcSEcCtD
Tirofiban—Swelling—Temsirolimus—kidney cancer	0.00542	0.0131	CcSEcCtD
Tirofiban—Hypercholesterolaemia—Everolimus—kidney cancer	0.00518	0.0125	CcSEcCtD
Tirofiban—Haemoptysis—Paclitaxel—kidney cancer	0.00372	0.009	CcSEcCtD
Tirofiban—Haematuria—Temsirolimus—kidney cancer	0.00352	0.00851	CcSEcCtD
Tirofiban—Myocardial infarction—Pazopanib—kidney cancer	0.0034	0.00824	CcSEcCtD
Tirofiban—Haematuria—Pazopanib—kidney cancer	0.00331	0.00802	CcSEcCtD
Tirofiban—Haemoglobin decreased—Capecitabine—kidney cancer	0.00328	0.00794	CcSEcCtD
Tirofiban—Haematemesis—Capecitabine—kidney cancer	0.00325	0.00787	CcSEcCtD
Tirofiban—Bradycardia—Pazopanib—kidney cancer	0.00317	0.00768	CcSEcCtD
Tirofiban—Haemoglobin—Pazopanib—kidney cancer	0.00313	0.00759	CcSEcCtD
Tirofiban—Haemorrhage—Pazopanib—kidney cancer	0.00312	0.00755	CcSEcCtD
Tirofiban—Haemoptysis—Capecitabine—kidney cancer	0.00305	0.00738	CcSEcCtD
Tirofiban—Chills—Temsirolimus—kidney cancer	0.00297	0.00719	CcSEcCtD
Tirofiban—Chills—Pazopanib—kidney cancer	0.0028	0.00677	CcSEcCtD
Tirofiban—Myocardial infarction—Vinblastine—kidney cancer	0.0027	0.00653	CcSEcCtD
Tirofiban—Myocardial infarction—Everolimus—kidney cancer	0.00269	0.00651	CcSEcCtD
Tirofiban—Haematuria—Everolimus—kidney cancer	0.00261	0.00633	CcSEcCtD
Tirofiban—Myocardial infarction—Erlotinib—kidney cancer	0.00259	0.00628	CcSEcCtD
Tirofiban—Hypertension—Temsirolimus—kidney cancer	0.00249	0.00602	CcSEcCtD
Tirofiban—Haemoglobin—Vinblastine—kidney cancer	0.00248	0.00601	CcSEcCtD
Tirofiban—Haemoglobin—Everolimus—kidney cancer	0.00247	0.00599	CcSEcCtD
Tirofiban—Haemorrhage—Vinblastine—kidney cancer	0.00247	0.00598	CcSEcCtD
Tirofiban—Haemorrhage—Everolimus—kidney cancer	0.00246	0.00596	CcSEcCtD
Tirofiban—Haemoglobin—Erlotinib—kidney cancer	0.00239	0.00578	CcSEcCtD
Tirofiban—Haemorrhage—Erlotinib—kidney cancer	0.00238	0.00575	CcSEcCtD
Tirofiban—Anaphylactic shock—Temsirolimus—kidney cancer	0.00235	0.00569	CcSEcCtD
Tirofiban—Oedema—Temsirolimus—kidney cancer	0.00235	0.00569	CcSEcCtD
Tirofiban—Hypertension—Pazopanib—kidney cancer	0.00234	0.00567	CcSEcCtD
Tirofiban—Myocardial infarction—Sorafenib—kidney cancer	0.00233	0.00565	CcSEcCtD
Tirofiban—Thrombocytopenia—Temsirolimus—kidney cancer	0.0023	0.00557	CcSEcCtD
Tirofiban—Swelling—Paclitaxel—kidney cancer	0.00226	0.00548	CcSEcCtD
Tirofiban—Oedema—Pazopanib—kidney cancer	0.00222	0.00536	CcSEcCtD
Tirofiban—Chills—Everolimus—kidney cancer	0.00221	0.00535	CcSEcCtD
Tirofiban—Thrombocytopenia—Pazopanib—kidney cancer	0.00217	0.00525	CcSEcCtD
Tirofiban—Haemoglobin—Sorafenib—kidney cancer	0.00215	0.0052	CcSEcCtD
Tirofiban—Hyperhidrosis—Pazopanib—kidney cancer	0.00214	0.00518	CcSEcCtD
Tirofiban—Haemorrhage—Sorafenib—kidney cancer	0.00214	0.00517	CcSEcCtD
Tirofiban—Chills—Erlotinib—kidney cancer	0.00213	0.00516	CcSEcCtD
Tirofiban—Haematemesis—Doxorubicin—kidney cancer	0.00209	0.00507	CcSEcCtD
Tirofiban—Bradycardia—Sunitinib—kidney cancer	0.00209	0.00507	CcSEcCtD
Tirofiban—Haemoglobin—Sunitinib—kidney cancer	0.00207	0.005	CcSEcCtD
Tirofiban—Haemorrhage—Sunitinib—kidney cancer	0.00206	0.00498	CcSEcCtD
Tirofiban—Pain—Temsirolimus—kidney cancer	0.00201	0.00487	CcSEcCtD
Tirofiban—Haemoptysis—Doxorubicin—kidney cancer	0.00197	0.00476	CcSEcCtD
Tirofiban—Myocardial infarction—Vincristine—kidney cancer	0.0019	0.0046	CcSEcCtD
Tirofiban—Pain—Pazopanib—kidney cancer	0.00189	0.00459	CcSEcCtD
Tirofiban—Body temperature increased—Temsirolimus—kidney cancer	0.00186	0.0045	CcSEcCtD
Tirofiban—Swelling—Capecitabine—kidney cancer	0.00186	0.0045	CcSEcCtD
Tirofiban—Hypertension—Vinblastine—kidney cancer	0.00186	0.0045	CcSEcCtD
Tirofiban—Sweating—Vincristine—kidney cancer	0.00186	0.0045	CcSEcCtD
Tirofiban—Hypertension—Everolimus—kidney cancer	0.00185	0.00448	CcSEcCtD
Tirofiban—Chills—Sunitinib—kidney cancer	0.00185	0.00447	CcSEcCtD
Tirofiban—Myocardial infarction—Gemcitabine—kidney cancer	0.0018	0.00436	CcSEcCtD
Tirofiban—Sweating—Gemcitabine—kidney cancer	0.00176	0.00427	CcSEcCtD
Tirofiban—Haematuria—Gemcitabine—kidney cancer	0.00175	0.00424	CcSEcCtD
Tirofiban—Oedema—Everolimus—kidney cancer	0.00175	0.00423	CcSEcCtD
Tirofiban—Chills—Dactinomycin—kidney cancer	0.00175	0.00423	CcSEcCtD
Tirofiban—Hypersensitivity—Temsirolimus—kidney cancer	0.00173	0.00419	CcSEcCtD
Tirofiban—Thrombocytopenia—Vinblastine—kidney cancer	0.00172	0.00416	CcSEcCtD
Tirofiban—Thrombocytopenia—Everolimus—kidney cancer	0.00171	0.00415	CcSEcCtD
Tirofiban—Hyperhidrosis—Everolimus—kidney cancer	0.00169	0.00409	CcSEcCtD
Tirofiban—Oedema—Erlotinib—kidney cancer	0.00169	0.00409	CcSEcCtD
Tirofiban—Haemoglobin—Gemcitabine—kidney cancer	0.00166	0.00401	CcSEcCtD
Tirofiban—Thrombocytopenia—Erlotinib—kidney cancer	0.00165	0.004	CcSEcCtD
Tirofiban—Haemorrhage—Gemcitabine—kidney cancer	0.00165	0.00399	CcSEcCtD
Tirofiban—Hypertension—Sorafenib—kidney cancer	0.00161	0.00389	CcSEcCtD
Tirofiban—Dizziness—Temsirolimus—kidney cancer	0.00156	0.00376	CcSEcCtD
Tirofiban—Hypertension—Sunitinib—kidney cancer	0.00155	0.00374	CcSEcCtD
Tirofiban—Anaphylactic shock—Sorafenib—kidney cancer	0.00152	0.00368	CcSEcCtD
Tirofiban—Myocardial infarction—Paclitaxel—kidney cancer	0.00151	0.00365	CcSEcCtD
Tirofiban—Pain—Vinblastine—kidney cancer	0.0015	0.00363	CcSEcCtD
Tirofiban—Pain—Everolimus—kidney cancer	0.0015	0.00362	CcSEcCtD
Tirofiban—Thrombocytopenia—Sorafenib—kidney cancer	0.00149	0.0036	CcSEcCtD
Tirofiban—Chills—Gemcitabine—kidney cancer	0.00148	0.00358	CcSEcCtD
Tirofiban—Headache—Temsirolimus—kidney cancer	0.00147	0.00357	CcSEcCtD
Tirofiban—Haematuria—Paclitaxel—kidney cancer	0.00147	0.00355	CcSEcCtD
Tirofiban—Dizziness—Pazopanib—kidney cancer	0.00146	0.00355	CcSEcCtD
Tirofiban—Oedema—Sunitinib—kidney cancer	0.00146	0.00354	CcSEcCtD
Tirofiban—Pain—Erlotinib—kidney cancer	0.00144	0.00349	CcSEcCtD
Tirofiban—Thrombocytopenia—Sunitinib—kidney cancer	0.00143	0.00346	CcSEcCtD
Tirofiban—Bradycardia—Paclitaxel—kidney cancer	0.00141	0.0034	CcSEcCtD
Tirofiban—Nausea—Temsirolimus—kidney cancer	0.0014	0.00338	CcSEcCtD
Tirofiban—Haemoglobin—Paclitaxel—kidney cancer	0.00139	0.00336	CcSEcCtD
Tirofiban—Headache—Pazopanib—kidney cancer	0.00139	0.00336	CcSEcCtD
Tirofiban—Oedema—Dactinomycin—kidney cancer	0.00138	0.00335	CcSEcCtD
Tirofiban—Body temperature increased—Everolimus—kidney cancer	0.00138	0.00335	CcSEcCtD
Tirofiban—Haemorrhage—Paclitaxel—kidney cancer	0.00138	0.00334	CcSEcCtD
Tirofiban—Thrombocytopenia—Dactinomycin—kidney cancer	0.00135	0.00328	CcSEcCtD
Tirofiban—Body temperature increased—Erlotinib—kidney cancer	0.00133	0.00323	CcSEcCtD
Tirofiban—Nausea—Pazopanib—kidney cancer	0.00132	0.00319	CcSEcCtD
Tirofiban—Hypertension—Vincristine—kidney cancer	0.00131	0.00316	CcSEcCtD
Tirofiban—Pain—Sorafenib—kidney cancer	0.0013	0.00314	CcSEcCtD
Tirofiban—Hypersensitivity—Vinblastine—kidney cancer	0.00129	0.00313	CcSEcCtD
Tirofiban—Hypersensitivity—Everolimus—kidney cancer	0.00129	0.00312	CcSEcCtD
Tirofiban—Pain—Sunitinib—kidney cancer	0.00125	0.00302	CcSEcCtD
Tirofiban—Hypertension—Gemcitabine—kidney cancer	0.00124	0.003	CcSEcCtD
Tirofiban—Chills—Paclitaxel—kidney cancer	0.00124	0.003	CcSEcCtD
Tirofiban—Myocardial infarction—Capecitabine—kidney cancer	0.00124	0.003	CcSEcCtD
Tirofiban—Oedema—Vincristine—kidney cancer	0.00124	0.00299	CcSEcCtD
Tirofiban—Anaphylactic shock—Vincristine—kidney cancer	0.00124	0.00299	CcSEcCtD
Tirofiban—Thrombocytopenia—Vincristine—kidney cancer	0.00121	0.00293	CcSEcCtD
Tirofiban—Urticaria—Sorafenib—kidney cancer	0.00121	0.00292	CcSEcCtD
Tirofiban—Haematuria—Capecitabine—kidney cancer	0.0012	0.00291	CcSEcCtD
Tirofiban—Body temperature increased—Sorafenib—kidney cancer	0.0012	0.00291	CcSEcCtD
Tirofiban—Hyperhidrosis—Vincristine—kidney cancer	0.00119	0.00289	CcSEcCtD
Tirofiban—Pain—Dactinomycin—kidney cancer	0.00118	0.00286	CcSEcCtD
Tirofiban—Oedema—Gemcitabine—kidney cancer	0.00117	0.00284	CcSEcCtD
Tirofiban—Anaphylactic shock—Gemcitabine—kidney cancer	0.00117	0.00284	CcSEcCtD
Tirofiban—Dizziness—Vinblastine—kidney cancer	0.00116	0.00281	CcSEcCtD
Tirofiban—Dizziness—Everolimus—kidney cancer	0.00116	0.0028	CcSEcCtD
Tirofiban—Body temperature increased—Sunitinib—kidney cancer	0.00115	0.0028	CcSEcCtD
Tirofiban—Bradycardia—Capecitabine—kidney cancer	0.00115	0.00279	CcSEcCtD
Tirofiban—Thrombocytopenia—Gemcitabine—kidney cancer	0.00115	0.00278	CcSEcCtD
Tirofiban—Haemoglobin—Capecitabine—kidney cancer	0.00114	0.00276	CcSEcCtD
Tirofiban—Haemorrhage—Capecitabine—kidney cancer	0.00113	0.00274	CcSEcCtD
Tirofiban—Hyperhidrosis—Gemcitabine—kidney cancer	0.00113	0.00274	CcSEcCtD
Tirofiban—Hypersensitivity—Sorafenib—kidney cancer	0.00112	0.00271	CcSEcCtD
Tirofiban—Dizziness—Erlotinib—kidney cancer	0.00112	0.0027	CcSEcCtD
Tirofiban—Headache—Vinblastine—kidney cancer	0.0011	0.00266	CcSEcCtD
Tirofiban—Headache—Everolimus—kidney cancer	0.0011	0.00265	CcSEcCtD
Tirofiban—Body temperature increased—Dactinomycin—kidney cancer	0.00109	0.00265	CcSEcCtD
Tirofiban—Hypersensitivity—Sunitinib—kidney cancer	0.00108	0.00261	CcSEcCtD
Tirofiban—Headache—Erlotinib—kidney cancer	0.00106	0.00256	CcSEcCtD
Tirofiban—Pain—Vincristine—kidney cancer	0.00106	0.00256	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—HNF1B—kidney cancer	0.00104	0.00178	CbGpPWpGaD
Tirofiban—Nausea—Vinblastine—kidney cancer	0.00104	0.00252	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—kidney cancer	0.00104	0.00177	CbGpPWpGaD
Tirofiban—Nausea—Everolimus—kidney cancer	0.00104	0.00252	CcSEcCtD
Tirofiban—Hypertension—Paclitaxel—kidney cancer	0.00104	0.00251	CcSEcCtD
Tirofiban—Hypersensitivity—Dactinomycin—kidney cancer	0.00102	0.00247	CcSEcCtD
Tirofiban—Chills—Capecitabine—kidney cancer	0.00102	0.00246	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—OR4C13—kidney cancer	0.00101	0.00172	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—PIK3CA—kidney cancer	0.00101	0.00172	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—BRAF—kidney cancer	0.001	0.00171	CbGpPWpGaD
Tirofiban—Dizziness—Sorafenib—kidney cancer	0.001	0.00243	CcSEcCtD
Tirofiban—Pain—Gemcitabine—kidney cancer	0.001	0.00243	CcSEcCtD
Tirofiban—Nausea—Erlotinib—kidney cancer	0.001	0.00243	CcSEcCtD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—RAF1—kidney cancer	0.001	0.00171	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—KCNMA1—kidney cancer	0.000998	0.0017	CbGpPWpGaD
Tirofiban—ITGB3—Integrins in angiogenesis—MAPK1—kidney cancer	0.000995	0.0017	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—MAPK3—kidney cancer	0.000984	0.00168	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Paclitaxel—kidney cancer	0.000982	0.00238	CcSEcCtD
Tirofiban—Oedema—Paclitaxel—kidney cancer	0.000982	0.00238	CcSEcCtD
Tirofiban—Body temperature increased—Vincristine—kidney cancer	0.000977	0.00236	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—CTNNA1—kidney cancer	0.000971	0.00165	CbGpPWpGaD
Tirofiban—ITGA2B—L1CAM interactions—MAPK3—kidney cancer	0.000969	0.00165	CbGpPWpGaD
Tirofiban—Dizziness—Sunitinib—kidney cancer	0.000966	0.00234	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—IGF2—kidney cancer	0.000966	0.00165	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Paclitaxel—kidney cancer	0.000961	0.00233	CcSEcCtD
Tirofiban—Headache—Sorafenib—kidney cancer	0.000951	0.0023	CcSEcCtD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—RAF1—kidney cancer	0.00095	0.00162	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Paclitaxel—kidney cancer	0.000949	0.0023	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—MAPK1—kidney cancer	0.000936	0.00159	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—BRAF—kidney cancer	0.000933	0.00159	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—PAX6—kidney cancer	0.000929	0.00158	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—MTOR—kidney cancer	0.000927	0.00158	CbGpPWpGaD
Tirofiban—Body temperature increased—Gemcitabine—kidney cancer	0.000927	0.00224	CcSEcCtD
Tirofiban—ITGA2B—L1CAM interactions—MAPK1—kidney cancer	0.000922	0.00157	CbGpPWpGaD
Tirofiban—Headache—Sunitinib—kidney cancer	0.000915	0.00222	CcSEcCtD
Tirofiban—ITGB3—Platelet degranulation—VEGFA—kidney cancer	0.000913	0.00156	CbGpPWpGaD
Tirofiban—Hypersensitivity—Vincristine—kidney cancer	0.00091	0.0022	CcSEcCtD
Tirofiban—Nausea—Sorafenib—kidney cancer	0.000902	0.00218	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—RAF1—kidney cancer	0.000896	0.00153	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—MAPK1—kidney cancer	0.000892	0.00152	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—MTOR—kidney cancer	0.000875	0.00149	CbGpPWpGaD
Tirofiban—ITGB3—IL4-mediated signaling events—PIK3CA—kidney cancer	0.000874	0.00149	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—GRB7—kidney cancer	0.000871	0.00148	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—VEGFA—kidney cancer	0.00087	0.00148	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—PAK1—kidney cancer	0.00087	0.00148	CbGpPWpGaD
Tirofiban—Nausea—Sunitinib—kidney cancer	0.000868	0.0021	CcSEcCtD
Tirofiban—ITGB3—Integrins in angiogenesis—PIK3CA—kidney cancer	0.000863	0.00147	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—LATS1—kidney cancer	0.000858	0.00146	CbGpPWpGaD
Tirofiban—Hypertension—Capecitabine—kidney cancer	0.000852	0.00206	CcSEcCtD
Tirofiban—Pain—Paclitaxel—kidney cancer	0.000839	0.00203	CcSEcCtD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—RAF1—kidney cancer	0.000838	0.00143	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—KDR—kidney cancer	0.00083	0.00141	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—KDR—kidney cancer	0.000828	0.00141	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—CTNNB1—kidney cancer	0.000822	0.0014	CbGpPWpGaD
Tirofiban—Nausea—Dactinomycin—kidney cancer	0.000822	0.00199	CcSEcCtD
Tirofiban—Dizziness—Vincristine—kidney cancer	0.000817	0.00198	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—PIK3CA—kidney cancer	0.000812	0.00138	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—MET—kidney cancer	0.000812	0.00138	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—ITPR2—kidney cancer	0.000809	0.00138	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—PAK1—kidney cancer	0.000806	0.00137	CbGpPWpGaD
Tirofiban—Oedema—Capecitabine—kidney cancer	0.000805	0.00195	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—RAF1—kidney cancer	0.000803	0.00137	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Capecitabine—kidney cancer	0.000789	0.00191	CcSEcCtD
Tirofiban—Sweating—Doxorubicin—kidney cancer	0.00078	0.00189	CcSEcCtD
Tirofiban—Urticaria—Paclitaxel—kidney cancer	0.00078	0.00189	CcSEcCtD
Tirofiban—Hyperhidrosis—Capecitabine—kidney cancer	0.000779	0.00188	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—RAF1—kidney cancer	0.000779	0.00133	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—OR4C13—kidney cancer	0.000777	0.00132	CbGpPWpGaD
Tirofiban—Haematuria—Doxorubicin—kidney cancer	0.000776	0.00188	CcSEcCtD
Tirofiban—Body temperature increased—Paclitaxel—kidney cancer	0.000776	0.00188	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—CTNNB1—kidney cancer	0.000776	0.00132	CbGpPWpGaD
Tirofiban—Headache—Vincristine—kidney cancer	0.000774	0.00187	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—IFNA1—kidney cancer	0.000771	0.00131	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—ERBB2—kidney cancer	0.00077	0.00131	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—CTNNA1—kidney cancer	0.000748	0.00127	CbGpPWpGaD
Tirofiban—ITGB3—L1CAM interactions—MAPK3—kidney cancer	0.000747	0.00127	CbGpPWpGaD
Tirofiban—Bradycardia—Doxorubicin—kidney cancer	0.000744	0.0018	CcSEcCtD
Tirofiban—Haemoglobin—Doxorubicin—kidney cancer	0.000735	0.00178	CcSEcCtD
Tirofiban—Headache—Gemcitabine—kidney cancer	0.000734	0.00178	CcSEcCtD
Tirofiban—Nausea—Vincristine—kidney cancer	0.000734	0.00178	CcSEcCtD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—JUN—kidney cancer	0.000731	0.00125	CbGpPWpGaD
Tirofiban—Haemorrhage—Doxorubicin—kidney cancer	0.000731	0.00177	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—AMER1—kidney cancer	0.000729	0.00124	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—VEGFA—kidney cancer	0.000724	0.00123	CbGpPWpGaD
Tirofiban—Hypersensitivity—Paclitaxel—kidney cancer	0.000723	0.00175	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—BRAF—kidney cancer	0.000718	0.00122	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—IFNA2—kidney cancer	0.000718	0.00122	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—PAX6—kidney cancer	0.000716	0.00122	CbGpPWpGaD
Tirofiban—ITGB3—L1CAM interactions—MAPK1—kidney cancer	0.00071	0.00121	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—PTEN—kidney cancer	0.000707	0.00121	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—KDR—kidney cancer	0.000703	0.0012	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—CDH1—kidney cancer	0.000702	0.0012	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—CCND1—kidney cancer	0.000702	0.0012	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—JUN—kidney cancer	0.0007	0.00119	CbGpPWpGaD
Tirofiban—Nausea—Gemcitabine—kidney cancer	0.000696	0.00169	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—RAF1—kidney cancer	0.00069	0.00118	CbGpPWpGaD
Tirofiban—Pain—Capecitabine—kidney cancer	0.000689	0.00167	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—MET—kidney cancer	0.000688	0.00117	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—MAPK1—kidney cancer	0.000687	0.00117	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—MAPK3—kidney cancer	0.000684	0.00117	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—VEGFA—kidney cancer	0.000683	0.00116	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—CCND1—kidney cancer	0.000681	0.00116	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—JUN—kidney cancer	0.000679	0.00116	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—CTNNB1—kidney cancer	0.000674	0.00115	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—LATS1—kidney cancer	0.000661	0.00113	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—PTEN—kidney cancer	0.000657	0.00112	CbGpPWpGaD
Tirofiban—Chills—Doxorubicin—kidney cancer	0.000656	0.00159	CcSEcCtD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—KRAS—kidney cancer	0.000655	0.00112	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—MAPK1—kidney cancer	0.000651	0.00111	CbGpPWpGaD
Tirofiban—Dizziness—Paclitaxel—kidney cancer	0.000649	0.00157	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—IGF2—kidney cancer	0.000646	0.0011	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—MAPK3—kidney cancer	0.000646	0.0011	CbGpPWpGaD
Tirofiban—Urticaria—Capecitabine—kidney cancer	0.00064	0.00155	CcSEcCtD
Tirofiban—ITGB3—Extracellular matrix organization—KDR—kidney cancer	0.000638	0.00109	CbGpPWpGaD
Tirofiban—Body temperature increased—Capecitabine—kidney cancer	0.000637	0.00154	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—PAK1—kidney cancer	0.000621	0.00106	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—IL2—kidney cancer	0.000619	0.00105	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—KRAS—kidney cancer	0.000615	0.00105	CbGpPWpGaD
Tirofiban—Headache—Paclitaxel—kidney cancer	0.000615	0.00149	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—MAPK1—kidney cancer	0.000615	0.00105	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CER1—kidney cancer	0.000611	0.00104	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—GPC3—kidney cancer	0.000611	0.00104	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—MAPK3—kidney cancer	0.000604	0.00103	CbGpPWpGaD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—PIK3CA—kidney cancer	0.000601	0.00102	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—RAF1—kidney cancer	0.0006	0.00102	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—IFNA1—kidney cancer	0.000594	0.00101	CbGpPWpGaD
Tirofiban—Hypersensitivity—Capecitabine—kidney cancer	0.000593	0.00144	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—ERBB2—kidney cancer	0.000593	0.00101	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—VEGFA—kidney cancer	0.000593	0.00101	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—MYC—kidney cancer	0.000588	0.001	CbGpPWpGaD
Tirofiban—Nausea—Paclitaxel—kidney cancer	0.000583	0.00141	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—KRAS—kidney cancer	0.000581	0.000989	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—MAPK1—kidney cancer	0.000575	0.00098	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—PIK3CA—kidney cancer	0.000565	0.000963	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—MYC—kidney cancer	0.000563	0.000959	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—AMER1—kidney cancer	0.000562	0.000957	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—IFNA2—kidney cancer	0.000553	0.000942	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—MAPK1—kidney cancer	0.000551	0.000938	CbGpPWpGaD
Tirofiban—Hypertension—Doxorubicin—kidney cancer	0.000549	0.00133	CcSEcCtD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—KRAS—kidney cancer	0.000543	0.000926	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—KDR—kidney cancer	0.000541	0.000922	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—CDH1—kidney cancer	0.000541	0.000921	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—MAPK1—kidney cancer	0.000534	0.00091	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—PIK3CA—kidney cancer	0.000533	0.000909	CbGpPWpGaD
Tirofiban—Dizziness—Capecitabine—kidney cancer	0.000533	0.00129	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—RAF1—kidney cancer	0.000531	0.000906	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—MET—kidney cancer	0.00053	0.000903	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	0.000526	0.000896	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—CCND1—kidney cancer	0.000524	0.000893	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—JUN—kidney cancer	0.000523	0.000891	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—SFRP2—kidney cancer	0.00052	0.000885	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Doxorubicin—kidney cancer	0.000519	0.00126	CcSEcCtD
Tirofiban—Oedema—Doxorubicin—kidney cancer	0.000519	0.00126	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—CTNNB1—kidney cancer	0.000519	0.000885	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Doxorubicin—kidney cancer	0.000508	0.00123	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—RAF1—kidney cancer	0.000508	0.000866	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—PTEN—kidney cancer	0.000506	0.000862	CbGpPWpGaD
Tirofiban—Headache—Capecitabine—kidney cancer	0.000505	0.00122	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—ERBB2—kidney cancer	0.000503	0.000856	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Doxorubicin—kidney cancer	0.000502	0.00122	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—KDR—kidney cancer	0.000501	0.000854	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—PIK3CA—kidney cancer	0.000499	0.00085	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—IGF2—kidney cancer	0.000498	0.000848	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	0.000497	0.000847	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—MET—kidney cancer	0.000491	0.000836	CbGpPWpGaD
Tirofiban—Nausea—Capecitabine—kidney cancer	0.000478	0.00116	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—IL2—kidney cancer	0.000477	0.000812	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	0.000473	0.000806	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CER1—kidney cancer	0.000471	0.000802	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—GPC3—kidney cancer	0.000471	0.000802	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—PIK3CA—kidney cancer	0.000463	0.00079	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—TP53—kidney cancer	0.000462	0.000787	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—VEGFA—kidney cancer	0.000457	0.000779	CbGpPWpGaD
Tirofiban—Pain—Doxorubicin—kidney cancer	0.000444	0.00107	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—AKAP13—kidney cancer	0.000419	0.000714	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CASP2—kidney cancer	0.000419	0.000714	CbGpPWpGaD
Tirofiban—Urticaria—Doxorubicin—kidney cancer	0.000412	0.000998	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—MAPK1—kidney cancer	0.000411	0.000701	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	0.000411	0.0007	CbGpPWpGaD
Tirofiban—Body temperature increased—Doxorubicin—kidney cancer	0.00041	0.000994	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	0.000405	0.00069	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SFRP2—kidney cancer	0.0004	0.000682	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—RAF1—kidney cancer	0.000391	0.000667	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—ERBB2—kidney cancer	0.000387	0.00066	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—VEGFA—kidney cancer	0.000387	0.00066	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—KDR—kidney cancer	0.000386	0.000658	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—GRB7—kidney cancer	0.000383	0.000653	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	0.000383	0.000653	CbGpPWpGaD
Tirofiban—Hypersensitivity—Doxorubicin—kidney cancer	0.000383	0.000926	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—MET—kidney cancer	0.000378	0.000644	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—MAPK3—kidney cancer	0.000366	0.000624	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	0.000365	0.000621	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—RAF1—kidney cancer	0.000363	0.000618	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—RELA—kidney cancer	0.000361	0.000615	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—ERBB2—kidney cancer	0.000359	0.000611	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—PIK3CA—kidney cancer	0.000357	0.000608	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ITPR2—kidney cancer	0.000356	0.000607	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—RAF1—kidney cancer	0.000356	0.000606	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—MAPK1—kidney cancer	0.000348	0.000594	CbGpPWpGaD
Tirofiban—Dizziness—Doxorubicin—kidney cancer	0.000343	0.000831	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—KRAS—kidney cancer	0.000329	0.000561	CbGpPWpGaD
Tirofiban—Headache—Doxorubicin—kidney cancer	0.000325	0.000787	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—CTNNA1—kidney cancer	0.000323	0.00055	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CASP2—kidney cancer	0.000323	0.00055	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—AKAP13—kidney cancer	0.000323	0.00055	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—EIF4EBP1—kidney cancer	0.000321	0.000547	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HSPB1—kidney cancer	0.000321	0.000547	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—IL2—kidney cancer	0.000319	0.000543	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	0.000316	0.000539	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—CTNNB1—kidney cancer	0.000314	0.000535	CbGpPWpGaD
Tirofiban—Nausea—Doxorubicin—kidney cancer	0.000308	0.000747	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—TSC1—kidney cancer	0.000298	0.000509	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ANXA1—kidney cancer	0.000298	0.000509	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PSMD7—kidney cancer	0.000298	0.000509	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—VEGFA—kidney cancer	0.000298	0.000508	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—GRB7—kidney cancer	0.000295	0.000503	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FLT1—kidney cancer	0.000289	0.000493	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—MAPK3—kidney cancer	0.000282	0.000481	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—RAF1—kidney cancer	0.000279	0.000476	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—RELA—kidney cancer	0.000278	0.000474	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—ERBB2—kidney cancer	0.000276	0.000471	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—VEGFA—kidney cancer	0.000276	0.000471	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ITPR2—kidney cancer	0.000274	0.000468	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—RAF1—kidney cancer	0.000274	0.000467	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—VEGFA—kidney cancer	0.000271	0.000462	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—MAPK1—kidney cancer	0.000268	0.000457	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PAK1—kidney cancer	0.000268	0.000457	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—JUNB—kidney cancer	0.000268	0.000457	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—MAPK3—kidney cancer	0.000261	0.000445	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—MAPK3—kidney cancer	0.000256	0.000437	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—KRAS—kidney cancer	0.000254	0.000432	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CTNNA1—kidney cancer	0.000249	0.000424	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—MAPK1—kidney cancer	0.000249	0.000424	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HSPB1—kidney cancer	0.000247	0.000421	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—EIF4EBP1—kidney cancer	0.000247	0.000421	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—IL2—kidney cancer	0.000246	0.000419	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—MAPK1—kidney cancer	0.000244	0.000416	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—CTNNB1—kidney cancer	0.000242	0.000412	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—KRAS—kidney cancer	0.000235	0.0004	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—KRAS—kidney cancer	0.00023	0.000393	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ANXA1—kidney cancer	0.00023	0.000392	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TSC1—kidney cancer	0.00023	0.000392	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PSMD7—kidney cancer	0.00023	0.000392	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FLT1—kidney cancer	0.000223	0.000379	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IGF2—kidney cancer	0.000219	0.000373	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CDKN2B—kidney cancer	0.000218	0.000372	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—VEGFA—kidney cancer	0.000213	0.000363	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IGF1R—kidney cancer	0.000212	0.000361	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—PIK3CA—kidney cancer	0.000212	0.000361	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—VEGFA—kidney cancer	0.000209	0.000356	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—JUNB—kidney cancer	0.000206	0.000352	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PAK1—kidney cancer	0.000206	0.000352	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—TP53—kidney cancer	0.000205	0.000349	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MAPK3—kidney cancer	0.000201	0.000343	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—MAPK3—kidney cancer	0.000197	0.000336	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MAPK1—kidney cancer	0.000192	0.000326	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—MAPK1—kidney cancer	0.000188	0.00032	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—KRAS—kidney cancer	0.000181	0.000308	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—KRAS—kidney cancer	0.000177	0.000302	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HIF1A—kidney cancer	0.000174	0.000297	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TSC2—kidney cancer	0.000174	0.000296	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IGF2—kidney cancer	0.000169	0.000288	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CDKN2B—kidney cancer	0.000168	0.000286	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—KDR—kidney cancer	0.000167	0.000284	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IGF1R—kidney cancer	0.000163	0.000278	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—PIK3CA—kidney cancer	0.000163	0.000278	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—TP53—kidney cancer	0.000158	0.000269	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—APC—kidney cancer	0.000154	0.000262	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—KIT—kidney cancer	0.000154	0.000262	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—POMC—kidney cancer	0.000146	0.000249	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—BRAF—kidney cancer	0.000144	0.000246	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HIF1A—kidney cancer	0.000134	0.000229	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TSC2—kidney cancer	0.000134	0.000228	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—KDR—kidney cancer	0.000128	0.000219	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—RAF1—kidney cancer	0.000121	0.000205	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—RELA—kidney cancer	0.00012	0.000205	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ERBB2—kidney cancer	0.000119	0.000203	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—APC—kidney cancer	0.000118	0.000202	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—KIT—kidney cancer	0.000118	0.000202	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MTOR—kidney cancer	0.000118	0.000201	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—POMC—kidney cancer	0.000113	0.000192	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—BRAF—kidney cancer	0.000111	0.00019	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CDKN1B—kidney cancer	0.00011	0.000188	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL2—kidney cancer	0.000108	0.000184	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CCND1—kidney cancer	0.000105	0.00018	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—JUN—kidney cancer	0.000105	0.000179	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CTNNB1—kidney cancer	0.000104	0.000178	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PTEN—kidney cancer	0.000102	0.000173	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—RAF1—kidney cancer	9.29e-05	0.000158	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—RELA—kidney cancer	9.25e-05	0.000158	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ERBB2—kidney cancer	9.19e-05	0.000157	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—VEGFA—kidney cancer	9.19e-05	0.000157	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MTOR—kidney cancer	9.07e-05	0.000155	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MAPK3—kidney cancer	8.69e-05	0.000148	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CDKN1B—kidney cancer	8.51e-05	0.000145	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MYC—kidney cancer	8.45e-05	0.000144	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL2—kidney cancer	8.33e-05	0.000142	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MAPK1—kidney cancer	8.27e-05	0.000141	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CCND1—kidney cancer	8.12e-05	0.000138	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—JUN—kidney cancer	8.1e-05	0.000138	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CTNNB1—kidney cancer	8.04e-05	0.000137	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PTEN—kidney cancer	7.84e-05	0.000134	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—KRAS—kidney cancer	7.81e-05	0.000133	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PIK3CA—kidney cancer	7.18e-05	0.000122	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—VEGFA—kidney cancer	7.08e-05	0.000121	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TP53—kidney cancer	6.94e-05	0.000118	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MAPK3—kidney cancer	6.7e-05	0.000114	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MYC—kidney cancer	6.51e-05	0.000111	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MAPK1—kidney cancer	6.37e-05	0.000109	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—KRAS—kidney cancer	6.02e-05	0.000103	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PIK3CA—kidney cancer	5.53e-05	9.42e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TP53—kidney cancer	5.35e-05	9.11e-05	CbGpPWpGaD
